Bedaquiline ( Sirturo , TMC207 ) , a diarylquinoline that inhibits mycobacterial ATP synthase , has been associated with accelerated sputum-culture conversion in patients with multidrug-resistant tuberculosis , when added to a preferred background regimen for 8 weeks .